Erectile Function Clinical Trial
Official title:
Ekstracorporal Shock Wave Therapy as a Treatment for Erectile Dysfunction in Men After Prostatectomy
Extra Corporal Shock wave Therapy Has proven effective as treatment with mild to moderate erectile dysfunction in men with erectile dysfunction. Investigator will examine whether the treatment also applies to men with moderate to severe erectile dysfunction after nerve injury associated with prostatectomy.
All patients have undergone prostatectomy and are without recurrence. None of the men have
sufficient effect of medical treatment for erectile dysfunction (tablets or injection
therapy).
Each participant will fill out two validated sexual function questionnaires: IIEF-5
(International Index of Erectile Function), and EHS (Erection Hardness Score).
Our treatment protocol consists of one treatment sessions per week for 5 wk. The shockwaves
are delivered to the distal, mid, and proximal penile shaft, and the left and right crura.
The duration of each LI-ESWT session was about 20min, and each session comprised 500 shocks
per treatment point (3000 per session) at an energy density of 0.15 mJ/mm2.
Patients are randomized to active treatment or placebo.By placebo added a blocking membrane
in the machine, handling is carried out exactly the same way as the active treatment. None
of the attending staff members will be familiar with who receive active and who receive
placebo treatment.
For evaluation, the International index of erectile function (IIEF-5) will be used after 1,
3- and 6-mo follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03790995 -
Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP
|
||
Recruiting |
NCT05853822 -
FirmTech User Research Trial
|
||
Completed |
NCT03389867 -
Open Label Study to Evaluate the Effect of Kaempferia Parviflora in Support of Erectile Function and Male Sexual Health
|
N/A |